As of Jun 23
| +0.075 / +0.69%|
The 1 analysts offering 12-month price forecasts for SciClone Pharmaceuticals Inc have a median target of 14.00, with a high estimate of 14.00 and a low estimate of 14.00. The median estimate represents a +27.85% increase from the last price of 10.95.
The current consensus among 1 polled investment analysts is to Hold stock in SciClone Pharmaceuticals Inc. This rating has held steady since June, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.